Author:
Marshall Helen,Clarke Michelle,Sullivan Thomas
Funder
National Health and Medical Research Council Career Development Fellowship
Faculty of Health Sciences New Appointment Funding
University of Adelaide, South Australia
Novartis Vaccines and Diagnostics Pty Ltd
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference27 articles.
1. Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18 to 36 months: a phase 1 randomized controlled clinical trial;Marshall;PIDJ,2012
2. Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial;Richmond;Lancet Infect Dis,2012
3. Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials;Vesikari;Lancet,2013
4. Immunogenicity and safety of a meningococcal serogroup A, C, Y and W glycoconjugate vaccine ACWY-TT;Findlow;Adv Ther,2013
5. Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers;Bruge;Vaccine,2004
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献